These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12686554)

  • 1. Functions of the activation loop in Csk protein-tyrosine kinase.
    Lin X; Lee S; Sun G
    J Biol Chem; 2003 Jun; 278(26):24072-7. PubMed ID: 12686554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
    Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
    J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk).
    Lee S; Ayrapetov MK; Kemble DJ; Parang K; Sun G
    J Biol Chem; 2006 Mar; 281(12):8183-9. PubMed ID: 16439366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.
    Lin X; Ayrapetov MK; Lee S; Parang K; Sun G
    Biochemistry; 2005 Feb; 44(5):1561-7. PubMed ID: 15683240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved hydrophobicity in the SH2-kinase linker is required for catalytic activity of Csk and CHK.
    Mikkola ET; Bergman M
    FEBS Lett; 2003 Jun; 544(1-3):11-4. PubMed ID: 12782282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants for Csk-catalyzed tyrosine phosphorylation of the Src tail.
    Wang D; Huang XY; Cole PA
    Biochemistry; 2001 Feb; 40(7):2004-10. PubMed ID: 11329267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
    Mikkola ET; Gahmberg CG
    J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the recognition of c-Src by its inactivator Csk.
    Levinson NM; Seeliger MA; Cole PA; Kuriyan J
    Cell; 2008 Jul; 134(1):124-34. PubMed ID: 18614016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, purification, and biochemical characterization of Chk, a soluble protein tyrosine kinase.
    Ayrapetov MK; Lee S; Sun G
    Protein Expr Purif; 2003 Jun; 29(2):148-55. PubMed ID: 12767803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.
    Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC
    Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase.
    Lee S; Lin X; Nam NH; Parang K; Sun G
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14707-12. PubMed ID: 14657361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical rescue of a mutant protein-tyrosine kinase.
    Williams DM; Wang D; Cole PA
    J Biol Chem; 2000 Dec; 275(49):38127-30. PubMed ID: 11006267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tyrosine kinase Csk dimerizes through Its SH3 domain.
    Levinson NM; Visperas PR; Kuriyan J
    PLoS One; 2009 Nov; 4(11):e7683. PubMed ID: 19888460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src.
    Sabe H; Hata A; Okada M; Nakagawa H; Hanafusa H
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3984-8. PubMed ID: 7513429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divalent ion effects and insights into the catalytic mechanism of protein tyrosine kinase Csk.
    Grace MR; Walsh CT; Cole PA
    Biochemistry; 1997 Feb; 36(7):1874-81. PubMed ID: 9048573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence specificity of C-terminal Src kinase (CSK)--a comparison with Src-related kinases c-Fgr and Lyn.
    Ruzzene M; Songyang Z; Marin O; Donella-Deana A; Brunati AM; Guerra B; Agostinis P; Cantley LC; Pinna LA
    Eur J Biochem; 1997 Jun; 246(2):433-9. PubMed ID: 9208935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.
    Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA
    Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Csk suppression of Src involves movement of Csk to sites of Src activity.
    Howell BW; Cooper JA
    Mol Cell Biol; 1994 Aug; 14(8):5402-11. PubMed ID: 7518562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Csk expressed in Escherichia coli is autophosphorylated on tyrosine residue(s).
    Bougeret C; Rothhut B; Jullien P; Fischer S; Benarous R
    Oncogene; 1993 May; 8(5):1241-7. PubMed ID: 7683130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.